Peer Review History
| Original SubmissionMarch 20, 2021 |
|---|
|
PONE-D-21-09224 Risk factors associated with the development of delirium. A prospective observational study PLOS ONE Dear Dr. LOBO VALBUENA, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Aleksandar R. Zivkovic Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2) Please update your title to reflect that the study assesses risk factors associated with delirium experienced in the ICU. 3) Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified: - whether consent was obtained - whether consent was informed - what type of consent you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). - if your study included minors, state whether you obtained consent from parents or guardians. - if the need for consent was waived by the ethics committee, please include this information. 4) We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer #1: Major and minor concerns: - Current Guidelines describe a meta-analysis of existing risk factors from a great number of studies and cohorts. So, the topic isn’t new and a lot of studies on delirium risk factors are available. The reported risk factors in this study aren’t innovative and go in line with current guidelines. A systematic comparison with risk factors from current guideline could be an additional result to add value to the manuscript. - A delirium incidence of 6.3% on an ICU is comparably low. Regarding a sensitive delirium screening (3 times a day with CAM-ICU), please describe your population more precisely, also the group of patients without delirium. Maybe your ICU population has lower risk for delirium compared to other populations (e.g. no heart surgery patients). - Who performed Delirium screening and Clinical Frailty Scale? Are these routine data from clinical staff? - Please put data from univariate analysis at least in a supplement. - The discussion should focus more on the results from multivariate analysis. The conclusion that sicker and older patients have a higher risk for delirium is too little, because it is know from preexisting literature. What is new? What is the difference? What implementation strategies will be made to prevent delirium on their ICU? It is a simple, well-executed prospective cohort description. Perhaps you can put some more work into comparing them to the existing literature and highlighting the specifics of their work. Reviewer #2: Overall: This is a somewhat clearly written manuscript outlining an observational study to identify risk factors of delirium. The project doesn’t really add anything new to the literature as no new risk factors have been identified. The low delirium rate in the population is problematic and the rationale for this has not been flushed out. Methodologic issues and limitations on reporting (standard of care, missing data) may have contributed to the findings. There are grammatical errors and word choices that impair understanding in some areas. Abstract: The abstract should clearly state that the dataset used is from a registry. Tool used for delirium detection is not provided in the abstract. Introduction: The introduction is a bit disorganized and doesn’t support the need for the project well. The authors propose delirium is under-recognized in the ICU but do not provide a reference for this statement. The authors list a number of risk factors for delirium, but there isn’t a statement about whether these are adequate. The limitations on prevention and treatments for ICU delirium has been outlined, but these are not tied to the study and how additional risk factors could/would modify patient care paradigms and/or improve outcomes. Methods: Page 4, paragraph 1: Please define use of the term ‘polyvalent’. This doesn’t seem to be the correct word. Page 4, paragraph 2: Please spell out the acronym RASS and provide a reference for this tool. While the project study subjects enrolled prospectively, the reliance on medical record data introduces potential for a substantial amount of missing data and this has not been addressed. A more detailed description of standard of care in relation to delirium should be provided. It would be helpful to know if the unit utilizes a ‘bundle’ (and which one) to prevent delirium which may contribute to the low delirium rate found in this study. Did subjects receive a daily sedation break? This would be important for evaluating the project. Please provide an operational definition of ‘organ failure’. Potential collinearity between variables may be a problem with the analysis but it does not appear this has been evaluated. Patients who are comatose can not be assessed with the CAM-ICU as they are not responsive. Subjects with coma on admission were included but it’s not clear how this was handled. It’s also not possible to assess patients for delirium while under complete neuromuscular blockade. How was the determination of delirium made or ruled out in these cases? Results: The delirium rate is very low for this cohort (6%). This should be discussed further within the manuscript. Missing data, especially for delirium assessment/identification, should be reported. Discussion and Limitations: Discussion of the low delirium rate is not well developed. Further exploration of this is necessary. Conclusions: Conclusions are very brief and don’t add to the manuscript. It is primarily a restatement of results and call to action for health care providers. Tables and Figures: Tables are helpful and provide additional content complementing the text. The figure is not viewable in the pdf. It is difficult to understand what is being presented or how it relates to the study. Reviewer #3: Thank you for this interesting article dealing with risk factors for the delirium occurence in ICU patients. The article is straightforward written and of clinical importance. However, there are still some points that need to be addressed in order to improve the article. Also, I have some concerns to recommend the acceptance of the present article, since there is a large amount of delirious publications existing and it should be well explained, how this present article may add and supplement the understanding of the delirium etiopathogenesis. I would therefore suggest to majorily revise your manuscript. - Headline should be more specific according to your study objectives. The setting should mentioned. Specify also the population on which your conclusion sould be drawn (general ICU patients, neurological/ surgical/ cardiovascular etc.). - The term „APACHE II before admission“ should be more specific. (in which direction is delirium risk increased?) - Correct „the use a bundle approach“, „its´“ - The second passage of the introduction should be better referenced after the second sentence. - Abbreviations (e.g. SCCM, CAM-ICU, RASS) should be written out when first used. Please add a abbreviation list for specification (for e.g. in the supplementary materials). - Inclusion and exclusion criteria sould be stated more profoundly. How was the willingness for study participation was ascertained when patients were sedated or could not communicate? Particularly in case of a delirium this is of major interest from an ethical point of view. - The „new data protection regulation“ – what is meant by this term. It is enough to state that the study protocol was approved by the Ethics Committee (EC). Please add the number you received from the EC, accordingly. - When did the CAM-ICU assessment take place. Please add a timeline/ timeframe. Who assessed the delirium state and how often was the assessment realized? What was the interrater-reliability like? - How was the SAP3 score SOFA score assessed. Please integrate this in the method section and specify who assessed the scores (by experienced physicians?). - p < .0001 should be changed to p < .001 - Please specify in the statistics sections: what is meant with the phrase „continuous variables were stratified…“. Please give an example. Also, „the cut-off point…“ was standardized. How was this standardized? What is meant by 0.1? Is it a p-value? - Also the recursive partitioning test sounds to me a bit arbitrary. Could you please give a reference for this method. On which base where the variables for classification chosen? Based on the results of the multivariate analysis? What does the understanding of the CHAID classification add to the results? - Please add „n = …“ when patient numbers are presented. - „In this group, reasons for ICU admission included pre-ICU emergency surgery or a medical admission (acute respiratory failure, sepsis, coma, or cardiac arrest)“ – Where can the rate of pre-ICU emergency surgery be drawn from the table? - Tables and figures should be presented chronologically after the manuscript text. - Finally, it should be more clarified what is new and outstanding on this research topic. What change in delirium management can be conveyed from your results? What does this imply for future research? - Give the reason why you state an evaluation of „moderate evidence“ for multiorgan function in the discussion section. - How is the post-ICU follow-up realized? This sounds very progressive and sounds interesting for future research and to become routine clinical practice for prevention of long-term complications from ICU. - Please speciy early aggressive treatment and other risk factors (other than what). - How would you address the fact that delirium is associated with a higher risk for need of invasive mechanical ventilation? Vice verse, mechanical ventilation may increase the risk for delirium evolvement. How or in which direction would you evaluate the causative path, based on your data? - Please let the Englisch language be checked via proof-reading by a native speaker. - Please add line numbers on each page to facilitate the review process. [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Risk factors associated with the development of delirium in general ICU patients. A prospective observational study. PONE-D-21-09224R1 Dear Dr. LOBO VALBUENA, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Aleksandar R. Zivkovic Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-09224R1 Risk factors associated with the development of delirium in general ICU patients. A prospective observational study. Dear Dr. Lobo-Valbuena: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Aleksandar R. Zivkovic Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .